AzTrials
AzTrials

Post-Traumatic HeadacheiCHARTNCT05093556

Interactive CBT for Headache And Relaxation Training

A study testing iCHART - Interactive CBT for Headache And Relaxation Training in people with Post-Traumatic Headache, run by VA Connecticut Healthcare System at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This mixed-methods pilot study aims to evaluate the feasibility, acceptability, and preliminary effectiveness of iCHART (Interactive CBT for Headache And Relaxation Training), an interactive voice response (IVR) based delivery of cognitive behavioral therapy for Veterans with post-traumatic headache. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Post-Traumatic Headache
What is being tested?
iCHART - Interactive CBT for Headache And Relaxation Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
6 Jan 2022to 1 Oct 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis of post-traumatic headache disorder (migraine and/or tension-type subtype)
  • Frequency of ≥4 headache days per month
  • Primary pain complaint of headache
  • Access to a touchtone telephone and computer/tablet

Who cannot join

  • Non-English speaking
  • Non-Veteran
  • Receiving hospice or palliative care
  • Sensory deficits that would impair participation in the IVR telephone calls
  • Significant cognitive impairment
  • Inpatient psychiatric hospitalization for any psychiatric or substance use diagnosis in the past 30 days from screening
  • Active psychotic symptoms, suicidality, or severe depressive symptoms
  • Suicidal and/or homicidal ideation in the past 6 months from screening

Trial locations and contacts

1 site in 1 country.

United States1 site
  • VACHS

    West Haven, Connecticut, 06516

Other trials in United States

About this study

Official title: Interactive CBT for Headache And Relaxation Training (iCHART)

This mixed-methods pilot study aims to evaluate the feasibility, acceptability, and preliminary effectiveness of iCHART (Interactive CBT for Headache And Relaxation Training), an interactive voice response (IVR) based delivery of cognitive behavioral therapy for Veterans with post-traumatic headache. Participants will receive iCHART treatment through the IVR system over a period of 10 weeks, which will include an automated daily assessment of patient-reported outcomes, retrieval of fortnightly tailored feedback from a study therapist, and additional weekly one-way motivational enhancement messaging. Delivery of traditional evidence-based behavioral treatments for headache management through technology-based interventions, such as IVR may ultimately increase much needed access to these treatments and allow patients to receive care at a time that is convenient for them.

Read the detailed description

Headache disorders are prevalent and highly disabling chronic neurological pain conditions, especially among women and people with traumatic brain injury, yet remain underdiagnosed and undertreated. Cognitive behavioral therapy for headache is an evidence-based psychological treatment that is effective in reducing headache frequency and severity, addressing psychiatric comorbidities, and improving an individual's quality of life, yet it remains hugely underutilized and inaccessible to many. Delivery of traditional evidence-based behavioral treatments for headache management through technology-based interventions may ultimately increase much needed access to these treatments. Interactive voice response (IVR) is an automated telephone-based technology where people receive tailored messaging which allows them to track symptoms, target behavior change, and engage in disease self-management. This mixed-methods pilot study aims to evaluate the feasibility, acceptability, and preliminary effectiveness of iCHART (Interactive CBT for Headache And Relaxation Training), an IVR-based delivery of cognitive behavioral therapy for Veterans with headache.

Participants will be thirty-five Veterans receiving care within VA Connecticut Healthcare System, who are diagnosed with post-traumatic headache. All eligible participants will complete an initial intake interview and a 28-day electronic headache diary. Following the baseline assessment period, eligible participants will then receive iCHART treatment through the IVR system over a period of 10 weeks, which will include an automated daily assessment of patient-reported outcomes, retrieval of fortnightly tailored feedback from a study therapist, and additional weekly one-way motivational enhancement messaging. Participants will access a patient workbook via the iCHART study website and iCHART providers will visualize patient-reported data through the secure iCHART provider dashboard. Assessment measures will be completed at baseline, immediately post-treatment completion, and one month post-treatment completion. Analysis of primary and secondary outcome measures will employ mixed methods.

Being tested
iCHART - Interactive CBT for Headache And Relaxation Training
Medical subject headings
Post-Traumatic Headache

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • iCHART - Interactive CBT for Headache And Relaxation TrainingBehavioural

    IVR based cognitive behavioral therapy for headache

Study groups in NCT05093556
Study groupRoleWhat they receive
iCHART - Interactive CBT for Headache And Relaxation TrainingExperimental10 week interactive-voice response technology (IVR) based cognitive behavioral therapy for headache
Receives: Behavioral: iCHART - Interactive CBT for Headache And Relaxation Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in headache days

    Daily self-reported headache days

    Measured: Baseline and week 14

Secondary outcomes (2)
  1. Change in headache-related disability

    Headache Disability Inventory (HDI) is a 25-item self-report questionnaire that assesses both emotional and functional impact of headache on daily activities. Item response options include "yes", "sometimes", and "no." Total scores range from 0 to 100. Higher scores indicate higher levels of reported disability.

    Measured: Baseline and week 14

  2. Change in headache-related disability

    Migraine Disability Assessment (MIDAS) is a 5-item, self-report measure of life disruption due to headache. Cut points represent thresholds for little or no disability (0-5), mild disability (6-10), moderate disability (11-20), and severe disability (21+).

    Measured: Baseline and week 14

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2021
  2. Study start6 Jan 2022
  3. Primary completion1 Oct 2023
  4. Study completion1 Oct 2023

Why it stopped: Change in vendor security protocols would have necessitated changing platforms and rebuilding entire IVR platform which would have delayed patient recruitment and introduced heterogeneity across subjects using current and new platforms

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05093556
Sponsor's protocol ID
AG001
Acronym
iCHART
Status last verified
Jan 2024
First submitted
22 Sep 2021
Last updated
10 Jan 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Grinberg AS, Rogers DG, Datre O, Anthony S, Clark SW, Takagishi SC, Seng E, Fenton BT, Ney JP, Sico JJ. Interactive CBT for headache and relaxation training (iCHART): Single-arm pilot trial of cognitive behavioral therapy for veterans with post-traumatic headache. Cephalalgia. 2025 Jul;45(7):3331024251351598. doi: 10.1177/03331024251351598. Epub 2025 Jul 14.

    PubMed 40657938

Questions about this trial

What is this clinical trial studying?

A study testing iCHART - Interactive CBT for Headache And Relaxation Training in people with Post-Traumatic Headache, run by VA Connecticut Healthcare System at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 10 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Change in vendor security protocols would have necessitated changing platforms and rebuilding entire IVR platform which would have delayed patient recruitment and introduced heterogeneity across subjects using current and new platforms). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in headache days (time frame: Baseline and week 14). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05093556, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jan 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in